Moody’s assigns Baa1 issuer rating to Sun Pharma; outlook stable
Moody’s Ratings assigned a Baa1 long-term issuer rating to Sun Pharmaceutical Industries Limited. The rating outlook is stable.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.